1. Home
  2. INAB vs LIDR Comparison

INAB vs LIDR Comparison

Compare INAB & LIDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • LIDR
  • Stock Information
  • Founded
  • INAB 2016
  • LIDR 2013
  • Country
  • INAB United States
  • LIDR United States
  • Employees
  • INAB N/A
  • LIDR N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • LIDR Auto Parts:O.E.M.
  • Sector
  • INAB Health Care
  • LIDR Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • LIDR Nasdaq
  • Market Cap
  • INAB 14.5M
  • LIDR 14.8M
  • IPO Year
  • INAB 2021
  • LIDR N/A
  • Fundamental
  • Price
  • INAB $2.16
  • LIDR $3.49
  • Analyst Decision
  • INAB Strong Buy
  • LIDR Hold
  • Analyst Count
  • INAB 2
  • LIDR 1
  • Target Price
  • INAB $108.00
  • LIDR N/A
  • AVG Volume (30 Days)
  • INAB 151.7K
  • LIDR 46.1M
  • Earning Date
  • INAB 08-07-2025
  • LIDR 07-31-2025
  • Dividend Yield
  • INAB N/A
  • LIDR N/A
  • EPS Growth
  • INAB N/A
  • LIDR N/A
  • EPS
  • INAB N/A
  • LIDR N/A
  • Revenue
  • INAB N/A
  • LIDR $246,000.00
  • Revenue This Year
  • INAB N/A
  • LIDR $2,677.23
  • Revenue Next Year
  • INAB N/A
  • LIDR $409.09
  • P/E Ratio
  • INAB N/A
  • LIDR N/A
  • Revenue Growth
  • INAB N/A
  • LIDR N/A
  • 52 Week Low
  • INAB $2.05
  • LIDR $0.49
  • 52 Week High
  • INAB $26.39
  • LIDR $6.44
  • Technical
  • Relative Strength Index (RSI)
  • INAB 38.73
  • LIDR 72.64
  • Support Level
  • INAB $2.12
  • LIDR $3.15
  • Resistance Level
  • INAB $2.57
  • LIDR $6.44
  • Average True Range (ATR)
  • INAB 0.14
  • LIDR 0.69
  • MACD
  • INAB 0.04
  • LIDR 0.25
  • Stochastic Oscillator
  • INAB 7.24
  • LIDR 48.83

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: